Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1401O Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)
Y. Y. Janjigian, Hanneke W.M. van Laarhoven, Sun Young Rha, V. Kozlov, D-Y. Oh, A. Gravina and 11 more
- Rank
- 99 of 3,853
- Percentile
- top 2.6%
- Where
- Annals of Oncology, 2024
- Citations
- 21
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.